Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Dec 20;8(12):e83179.
doi: 10.1371/journal.pone.0083179. eCollection 2013.

Rotor termination is critically dependent on kinetic properties of I kur inhibitors in an in silico model of chronic atrial fibrillation

Affiliations

Rotor termination is critically dependent on kinetic properties of I kur inhibitors in an in silico model of chronic atrial fibrillation

Eberhard P Scholz et al. PLoS One. .

Abstract

Inhibition of the atrial ultra-rapid delayed rectifier potassium current (I Kur) represents a promising therapeutic strategy in the therapy of atrial fibrillation. However, experimental and clinical data on the antiarrhythmic efficacy remain controversial. We tested the hypothesis that antiarrhythmic effects of I Kur inhibitors are dependent on kinetic properties of channel blockade. A mathematical description of I Kur blockade was introduced into Courtemanche-Ramirez-Nattel models of normal and remodeled atrial electrophysiology. Effects of five model compounds with different kinetic properties were analyzed. Although a reduction of dominant frequencies could be observed in two dimensional tissue simulations for all compounds, a reduction of spiral wave activity could be only be detected in two cases. We found that an increase of the percent area of refractory tissue due to a prolongation of the wavelength seems to be particularly important. By automatic tracking of spiral tip movement we find that increased refractoriness resulted in rotor extinction caused by an increased spiral-tip meandering. We show that antiarrhythmic effects of I Kur inhibitors are dependent on kinetic properties of blockade. We find that an increase of the percent area of refractory tissue is the underlying mechanism for an increased spiral-tip meandering, resulting in the extinction of re-entrant circuits.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Electrophysiological properties of cAF tissue.
(A) Simulated AP recordings of isolated cells from normal (solid line) and remodeled atrial tissue (dashed line). (B) Restitution of ERP under physiological conditions (solid lines) and cAF (dashed lines). (C, D) CV and WL restitution for physiological conditions (solid lines) and cAF (dashed lines).
Figure 2
Figure 2. Pharmacological properties of simulated I Kur inhibition.
(A) Effect of inhibition on I Kur elicited by a simulated voltage step (500 ms) to +30 mV (see inset). (B) Effect of the different inhibitory model compounds on AP trajectories in cells from normal atrial tissue. (C) Depending on the kinetic properties, I Kur inhibition resulted in an elevation of the plateau potential (#1, #2, and #3) as well as AP prolongation (#1, #2, #3, and #5) in cells from cAF tissue. (D) Effects of onset and recovery time constants on the non-blocked fraction of I Kur blockade established at a pacing rate of 1 Hz. The underlying AP derived from a cAF cell is depicted in a dashed line.
Figure 3
Figure 3. Electrophysiological properties of remodeled atrial tissue under I Kur inhibition.
Restitution curves of the APD (A), ERP (B), CV (C), and WL (D) under different types of I Kur inhibition. Whereas APD, ERP, and WL restitution exhibits a strong dependence on kinetic properties of I Kur inhibitors, the CV is not affected.
Figure 4
Figure 4. Percent area of refractory tissue.
(A) Spiral wave activity of a single rotor under control cAF conditions and after inhibition with all five test compounds displayed at the end of the 5th second. The transmembrane voltage is color-coded with blue representing −80 mV and yellow representing 0 mV. (B) Summarized data of the mean percentage of refractory tissue quantified over the last 4 seconds of inhibition (control: 17.2%, #1: 22.2%, #2: 16.8%, #3: 19.1%, #4: 16.6%, #5: 16.2%).
Figure 5
Figure 5. Automated analysis of spiral wave activity.
(A) Sequence of images (in 20 ms steps) of spiral wave activity under control cAF conditions starting at the 10th second. The transmembrane voltage is color-coded with blue representing −80 mV and yellow representing 0 mV. (B) Exemplary time interval (10th to 15th second) of the simulated unipolar pseudo-electrocardiogram (pseudo-ECG) recorded at the center of the atrial layer under control conditions. (C) Normalized power spectral density of atrial activation derived from the pseudo-ECG. (D) Number of rotors automatically detected by our analysis algorithm.
Figure 6
Figure 6. Rotor analysis under pharmacological I Kur inhibition.
(A) Number of spiral waves followed over a time period of 30 seconds. (B) Normalized power spectral density of electrical activity in remodeled tissue under control conditions and under I Kur inhibition.
Figure 7
Figure 7. Effects of I Kur inhibition on spiral tip meandering.
Spatiotemporal arrangement of the spiral tips followed over a period of 30(color coded time scale: blue = early, red = late). Under control cAF conditions (A), five rotor centers were detected with high spatiotemporal stability. Similar results were obtained for the inhibitory compounds #2 (C), #4 (E), and #5 (F). However, when applying the compound #1 (B) or compound #3 (D), pronounced destabilization was observed paralleled by an extinction of rotors.

References

    1. Dobrev D, Nattel S (2010) New antiarrhythmic drugs for treatment of atrial fibrillation. The Lancet 375: 1212–1223 10.1016/S0140-6736(10)60096-7 - DOI - PubMed
    1. Ehrlich JR, Biliczki P, Hohnloser SH, Nattel S (2008) Atrial-selective approaches for the treatment of atrial fibrillation. Journal of the American College of Cardiology 51: 787–792 10.1016/j.jacc.2007.08.067 - DOI - PubMed
    1. Nattel S (2002) New ideas about atrial fibrillation 50 years on. Nature 415: 219–226 10.1038/415219a - DOI - PubMed
    1. Nattel S, Carlsson L (2006) Innovative approaches to anti-arrhythmic drug therapy. Nat Rev Drug Discov 5: 1034–1049 10.1038/nrd2112 - DOI - PubMed
    1. Nattel S, Yue L, Wang Z (1999) Cardiac ultrarapid delayed rectifiers: a novel potassium current family o f functional similarity and molecular diversity. Cell Physiol Biochem 9: 217–226. - PubMed

Publication types

MeSH terms

Substances